Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Abstract Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination therapies. This study aimed to evalu...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2025-04-01
Schriftenreihe:	Cardiology and Therapy
Schlagworte:	Hypertension Cardiovascular disease Losartan Chlorthalidone Hydrochlorothiazide
Online-Zugang:	https://doi.org/10.1007/s40119-025-00407-7
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!